Z-13752A

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameZ-13752A
Drug Alias NameZ-13752AGW-660511X
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme inhibitorsNeprilysin inhibitors
TargetsAngiotensin-converting enzymeNeprilysin
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesZambon
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesZambonGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeN/A
Related LinksN/A